159 related articles for article (PubMed ID: 26387546)
1. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.
Ferrer I; Verdugo-Sivianes EM; Castilla MA; Melendez R; Marin JJ; Muñoz-Galvan S; Lopez-Guerra JL; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Perez M; Palacios J; Carnero A
Oncogene; 2016 May; 35(21):2777-88. PubMed ID: 26387546
[TBL] [Abstract][Full Text] [Related]
2. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
Verdugo-Sivianes EM; Rojas AM; Muñoz-Galván S; Otero-Albiol D; Carnero A
Theranostics; 2021; 11(7):3452-3471. PubMed ID: 33537097
[No Abstract] [Full Text] [Related]
3. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
Estevez-Garcia P; Lopez-Calderero I; Molina-Pinelo S; Muñoz-Galvan S; Salinas A; Gomez-Izquierdo L; Lucena-Cacace A; Felipe-Abrio B; Paz-Ares L; Garcia-Carbonero R; Carnero A
Clin Cancer Res; 2013 Jul; 19(14):3925-35. PubMed ID: 23729363
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.
Molina-Pinelo S; Ferrer I; Blanco-Aparicio C; Peregrino S; Pastor MD; Alvarez-Vega J; Suarez R; Verge M; Marin JJ; Hernandez-Losa J; Ramon y Cajal S; Paz-Ares L; Carnero A
J Pathol; 2011 Sep; 225(1):73-82. PubMed ID: 21598252
[TBL] [Abstract][Full Text] [Related]
5. Spinophilin: a new tumor suppressor at 17q21.
Carnero A
Curr Mol Med; 2012 Jun; 12(5):528-35. PubMed ID: 22515982
[TBL] [Abstract][Full Text] [Related]
6. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.
Ferrer I; Blanco-Aparicio C; Peregrina S; Cañamero M; Fominaya J; Cecilia Y; Lleonart M; Hernandez-Losa J; Ramon y Cajal S; Carnero A
Cell Cycle; 2011 Aug; 10(16):2751-62. PubMed ID: 21772120
[TBL] [Abstract][Full Text] [Related]
7. Spinophilin loss contributes to tumorigenesis in vivo.
Ferrer I; Peregrino S; Cañamero M; Cecilia Y; Blanco-Aparicio C; Carnero A
Cell Cycle; 2011 Jun; 10(12):1948-55. PubMed ID: 21670604
[TBL] [Abstract][Full Text] [Related]
8. Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer.
Verdugo-Sivianes EM; Navas L; Molina-Pinelo S; Ferrer I; Quintanal-Villalonga A; Peinado J; Garcia-Heredia JM; Felipe-Abrio B; Muñoz-Galvan S; Marin JJ; Montuenga L; Paz-Ares L; Carnero A
Oncotarget; 2017 Dec; 8(62):105196-105210. PubMed ID: 29285244
[TBL] [Abstract][Full Text] [Related]
9. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
10. SPINOPHILIN: A multiplayer tumor suppressor.
Verdugo-Sivianes EM; Carnero A
Genes Dis; 2023 Jan; 10(1):187-198. PubMed ID: 37013033
[TBL] [Abstract][Full Text] [Related]
11. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
12. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Schwarzenbacher D; Stiegelbauer V; Deutsch A; Ress AL; Aigelsreiter A; Schauer S; Wagner K; Langsenlehner T; Resel M; Gerger A; Ling H; Ivan C; Calin GA; Hoefler G; Rinner B; Pichler M
Oncotarget; 2015 May; 6(13):11191-202. PubMed ID: 25857299
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
Oon ML; Thike AA; Tan SY; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):31-41. PubMed ID: 25677743
[TBL] [Abstract][Full Text] [Related]
15. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
16. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
